Cortical thinning in vascular mild cognitive impairment and vascular dementia of subcortical type

Sang Won Seo1, Jaewon Ahn, Uicheul Yoon

  • 1Department of Neurology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.

Abstract

Insights

Subcortical vascular mild cognitive impairment (svMCI) and subcortical vascular dementia (SVaD) show distinct patterns of cortical thinning. Cognitive decline from svMCI to SVaD involves additional lesions in specific brain regions.

Area of Science:

  • Neurology
  • Neuroimaging
  • Cognitive Science

Background:

  • Amnestic mild cognitive impairment (MCI) precedes Alzheimer's disease (AD).
  • Subcortical vascular mild cognitive impairment (svMCI) may precede subcortical vascular dementia (SVaD).
  • Cortical thinning patterns and ischemia ratings on MRI can elucidate SVaD and svMCI pathogenesis.

Purpose of the Study:

  • Determine differences in cortical atrophy distribution between svMCI and SVaD.
  • Understand the hierarchy between svMCI and SVaD.
  • Investigate the evolution of svMCI into SVaD.

Main Methods:

  • Magnetic resonance imaging (MRI) with 3D volumetric images.
  • Cortical thickness analysis across the entire brain.
  • Comparison of svMCI, SVaD, AD, and normal cognition (NC) groups.

Main Results:

  • svMCI patients showed cortical thinning in frontal, orbitofrontal, cingulate, insula, temporal, and lingual gyri compared to NC.
  • SVaD patients exhibited thinning in all areas affected by svMCI, plus dorsolateral prefrontal and temporal cortices.
  • Distinct patterns of cortical atrophy differentiate svMCI from SVaD.

Conclusions:

  • Findings suggest a hierarchical relationship between svMCI and SVaD.
  • Cognitive decline from svMCI to SVaD is linked to lesions in dorsolateral prefrontal and temporal cortices.
  • Cortical atrophy patterns provide insights into the progression of vascular cognitive impairment.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...